{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:07:48Z","timestamp":1787497668482,"version":"build-2736575974"},"reference-count":0,"publisher":"SanovaWorks","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JDD"],"published-print":{"date-parts":[[2023,4,1]]},"DOI":"10.36849\/jdd.7098","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:11:02Z","timestamp":1680862262000},"page":"425-427","source":"Crossref","is-referenced-by-count":16,"title":["Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)"],"prefix":"10.36849","volume":"22","author":[{"given":"Sarah","family":"Alsukait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Learned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosmarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22713","published-online":{"date-parts":[[2023,3,1]]},"container-title":["Journal of Drugs in Dermatology"],"original-title":[],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:11:25Z","timestamp":1680862285000},"score":1,"resource":{"primary":{"URL":"https:\/\/jddonline.com\/articles\/dermatology\/S1545961623P0425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.36849\/jdd.7098","relation":{},"ISSN":["1545-9616"],"issn-type":[{"value":"1545-9616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}